XML 57 R43.htm IDEA: XBRL DOCUMENT v3.23.2
Long-Term Obligations - Additional Information (Detail)
6 Months Ended 12 Months Ended
Oct. 15, 2022
Days
Jun. 30, 2023
USD ($)
Days
$ / shares
shares
Dec. 31, 2022
USD ($)
Oct. 26, 2018
USD ($)
Oct. 16, 2018
USD ($)
Subsequent Event [Line Items]          
Debt instrument convertible threshold consecutive trading days | Days   5      
Description of debt instrument convertible period   during the five-business day period immediately after any five consecutive trading day period      
Principal amount of notes used in conversion rate   $ 1,000      
Debt instrument convertible threshold maximum percentage of product of last reported sale price of common stock   98.00%      
Fair Value of embeded derivative liability   $ 2,800,000 $ 2,800,000    
Level 3 [Member]          
Subsequent Event [Line Items]          
Fair Value of embeded derivative liability   2,800,000 2,800,000    
Deferred Royalty Obligation [Member] | Level 3 [Member]          
Subsequent Event [Line Items]          
Deferred royalty obligation at fair value   129,900,000 129,900,000    
Revenue Interest Financing Agreement [Member]          
Subsequent Event [Line Items]          
Debt issuance costs   1,400,000      
First investment amount   $ 75,000,000      
Revenue Interest Financing Agreement [Member] | HealthCare Royalty Partners IV LP [Member] | Royalty Due On December 31, 2024 [Member]          
Subsequent Event [Line Items]          
Royalty Payable Percentage on First Investment Amount   100.00%      
Revenue Interest Financing Agreement [Member] | HealthCare Royalty Partners IV LP [Member] | Royalty Due On September 30, 2026 [Member]          
Subsequent Event [Line Items]          
Royalty Payable Percentage on First Investment Amount   100.00%      
Royalty Payable Percentage on Second Investment Amount   100.00%      
Amended Revenue Interest Agreement [Member]          
Subsequent Event [Line Items]          
Second investment amount   $ 60,000,000      
Amended Revenue Interest Agreement [Member] | HealthCare Royalty Partners IV LP [Member] | Royalty Due On December 31, 2024 [Member]          
Subsequent Event [Line Items]          
Royalty Payable Percentage on Second Investment Amount   65.00%      
Revenue Interest Agreement And Amended Revenue Interest Agreement [Member]          
Subsequent Event [Line Items]          
First investment amount   $ 135,000,000 135,000,000    
Debt Instrument Interest Rate   14.00%      
Revenue Interest Agreement And Amended Revenue Interest Agreement [Member] | HealthCare Royalty Partners IV LP [Member]          
Subsequent Event [Line Items]          
Aggregate Royalties Percentage   185.00%      
Cumulative payments   $ 53,800,000      
Convertible Note Offering [Member]          
Subsequent Event [Line Items]          
Notes converted in to common stock, amount | shares   63.0731      
Notes converted in to common stock, shares   $ 1,000      
Notes, conversion price per share | $ / shares   $ 15.85      
3% Convertible Senior Notes Due 2025 [Member]          
Subsequent Event [Line Items]          
Aggregate principal amount   $ 172,500,000 172,500,000 $ 22,500,000 $ 150,000,000
Debt issuance costs   $ 5,600,000      
Debt discount and issuance costs amortized to interest expense, amortization period   7 years      
Notes, interest rate   3.00%      
Notes, maturity date   Oct. 15, 2025      
Principal amount of notes used in conversion rate   $ 1,000      
Debt instrument, convertible latest date   Jun. 15, 2025      
Notes conversion price, percentage 130.00% 130.00%      
Notes instrument, trading days | Days 20 20      
Debt instrument convertible threshold consecutive trading days | Days 30 30      
Notes, repurchase price 100.00%        
Estimated fair value of convertible notes   $ 115,400,000 $ 133,100,000    
Expected life of convertible notes   7 years      
Debt Instrument Interest Rate   3.53%